BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB. CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020. MMWR Recomm Rep. 2020;69:1-17. [PMID: 32271723 DOI: 10.15585/mmwr.rr6902a1] [Cited by in Crossref: 169] [Cited by in F6Publishing: 182] [Article Influence: 84.5] [Reference Citation Analysis]
Number Citing Articles
1 Foster MA, Moorman AC, Teshale EH. Hepatitis C Virus. Principles and Practice of Pediatric Infectious Diseases 2023. [DOI: 10.1016/b978-0-323-75608-2.00220-2] [Reference Citation Analysis]
2 Khanna D, Kar P. Can the diagnostics of hepatitis in pregnant patients be improved? Expert Review of Molecular Diagnostics 2022. [DOI: 10.1080/14737159.2022.2153039] [Reference Citation Analysis]
3 Jones A, Schneider K, Falade-nwulia O, Sterner G, Tobin K, Latkin C. Social Networks, Stigma, and Hepatitis C Care Among Women Who Inject Drugs: Findings from A Community Recruited Sample. Journal of Psychoactive Drugs 2022. [DOI: 10.1080/02791072.2022.2129886] [Reference Citation Analysis]
4 Kendig NE, Butkus R, Mathew S, Hilden D, Health and Public Policy Committee of the American College of Physicians. Health Care During Incarceration: A Policy Position Paper From the American College of Physicians. Ann Intern Med 2022. [DOI: 10.7326/m22-2370] [Reference Citation Analysis]
5 Yee LM, Shah SK, Grobman WA, Labellarte PZ, Barrera L, Jhaveri R. Identifying barriers and facilitators of the inclusion of pregnant individuals in hepatitis C treatment programs in the United States. PLoS ONE 2022;17:e0277987. [DOI: 10.1371/journal.pone.0277987] [Reference Citation Analysis]
6 Kim BK. How to Optimize the Care Cascade of Hepatitis C Virus Infection. Gut and Liver 2022;16:809-810. [DOI: 10.5009/gnl220452] [Reference Citation Analysis]
7 Ahrens KA, Rossen LM, Burgess AR, Palmsten K, Ziller EC. Maternal hepatitis C prevalence and trends by county, US : 2016–2020. Paediatric Perinatal Epid 2022. [DOI: 10.1111/ppe.12934] [Reference Citation Analysis]
8 Rădoi CL, Berbecaru E, Istrate-ofițeru A, Nagy RD, Drăgușin RC, Căpitănescu RG, Zorilă MV, Zorilă LG, Iliescu DG. Intrauterine Transmission of Hepatitis C Virus Concomitant with Isolated Severe Fetal Ascites. Pathogens 2022;11:1335. [DOI: 10.3390/pathogens11111335] [Reference Citation Analysis]
9 Woodworth KR, Newton SM, Olsen EO, Tannis A, Sizemore L, Wingate H, Orkis L, Reynolds B, Longcore N, Thomas N, Bocour A, Wills A, Kim SY, Panagiotakopoulos L, Wester C, Delman Meaney D, Gilboa SM, Tong VT. Timing of Positive Hepatitis C Virus Test Results During and 1 Year Before Pregnancy. Obstetrics & Gynecology 2022;Publish Ahead of Print. [DOI: 10.1097/aog.0000000000004980] [Reference Citation Analysis]
10 Kushner T, Djerboua M, Biondi MJ, Feld JJ, Terrault N, Flemming JA. Influence of hepatitis C viral parameters on pregnancy complications and risk of mother-to-child transmission. J Hepatol 2022;77:1256-64. [PMID: 35643203 DOI: 10.1016/j.jhep.2022.05.016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zijlstra MK, Fidel Nague K, Louie P, Imas P, Sonnenberg A, Fimmel CJ. Successful Hepatitis C Birth Cohort Screening and Linkage to Care in a US Community Health System. J Public Health Manag Pract 2022;28:E825-30. [PMID: 36194824 DOI: 10.1097/PHH.0000000000001590] [Reference Citation Analysis]
12 Park H, Lo-Ciganic WH, Huang J, Wu Y, Henry L, Peter J, Sulkowski M, Nelson DR. Evaluation of machine learning algorithms for predicting direct-acting antiviral treatment failure among patients with chronic hepatitis C infection. Sci Rep 2022;12:18094. [PMID: 36302828 DOI: 10.1038/s41598-022-22819-4] [Reference Citation Analysis]
13 Chia CT, Bender AT, Lillis L, Sullivan BP, Martin CD, Burke W, Landis C, Boyle DS, Posner JD. Rapid detection of hepatitis C virus using recombinase polymerase amplification. PLoS One 2022;17:e0276582. [PMID: 36282844 DOI: 10.1371/journal.pone.0276582] [Reference Citation Analysis]
14 Huang Y, Shen F, Ye Z. Do Storytelling and Processing Motivation Matter? Comparing Narratives and Exemplars in Promoting Hepatitis C Screening among College Students. J Health Commun 2022;:1-10. [PMID: 36268767 DOI: 10.1080/10810730.2022.2134521] [Reference Citation Analysis]
15 Varley CD, Conte M, Streifel AC, Winders B, Sikka MK. Screening for co-infections in patients with substance use disorders and severe bacterial infections. Ther Adv Infect Dis 2022;9:20499361221132132. [PMID: 36277297 DOI: 10.1177/20499361221132132] [Reference Citation Analysis]
16 Lee DH, Chou EY, Moore K, Melly S, Zhao Y, Chen H, Buehler JW. Patient characteristics and neighborhood attributes associated with hepatitis C screening and positivity in Philadelphia. Prev Med Rep 2022;30:102011. [PMID: 36245804 DOI: 10.1016/j.pmedr.2022.102011] [Reference Citation Analysis]
17 Chastain CA, Jenkins CA, Rose M, Moore D, Parker D, Cave B, Crowe J, Adams S, Rubio MG, Potter R, Quedado K, Jones ID, Han JH, Self WH. Non‐targeted hepatitis C virus screening in acute care healthcare settings in the Southern Appalachian region. JACEP Open 2022;3. [DOI: 10.1002/emp2.12819] [Reference Citation Analysis]
18 Jiang X, Diaby V, Vouri SM, Lo-ciganic W, Parker RL, Wang W, Chang S, Wilson DL, Henry L, Park H. Economic Impact of Universal Hepatitis C Virus Testing for Middle-Aged Adults Who Inject Drugs. American Journal of Preventive Medicine 2022. [DOI: 10.1016/j.amepre.2022.08.016] [Reference Citation Analysis]
19 Lyons MS, Chawarski MC, Rothman R, Whiteside L, Cowan E, Richardson LD, Hawk K, Tsui JI, Schwartz RP, O'Connor P, D'Onofrio G, Fiellin DA, Edelman EJ. Missed Opportunities for HIV and Hepatitis C Screening Among Emergency Department Patients With Untreated Opioid Use Disorder. J Addict Med 2022. [PMID: 36170184 DOI: 10.1097/ADM.0000000000001074] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Lee AW, Jacobs W, Tran M, Nguyen B, Hua DN, Ho JN, Van Nguyen T. Sociodemographic characteristics associated with hepatitis C virus infection in Vietnamese Americans: A cross-sectional analysis of community screening data. PLoS ONE 2022;17:e0275210. [DOI: 10.1371/journal.pone.0275210] [Reference Citation Analysis]
21 Chang S, Hu H, Chen Y, Yen Y, Huang N. Late hepatitis C virus diagnosis among patients with newly diagnosed hepatocellular carcinoma: a case–control study. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02504-6] [Reference Citation Analysis]
22 Abdul Massih S, Eke AC. Direct antiviral agents (DAAs) and their use in pregnant women with hepatitis C (HCV). Expert Review of Anti-infective Therapy. [DOI: 10.1080/14787210.2022.2125868] [Reference Citation Analysis]
23 Valdez KE, Javanbakht M, Keith K, Archer R, Deng JZ, Marx SE, Kuznetsova A, Dylla DE, Klausner JD. Healthcare resource utilization in Hepatitis C-infected patients completing eight versus twelve weeks of treatment: A retrospective cohort study. Front Gastroenterol 2022;1. [DOI: 10.3389/fgstr.2022.988971] [Reference Citation Analysis]
24 Celeste-villalvir A, Wilkerson JM, Markham C, Rodriguez L, Schick V. A qualitative investigation of organizational challenges and facilitators to screening individuals experiencing homelessness for hepatitis C virus (HCV) in Houston, Texas. PLoS ONE 2022;17:e0273302. [DOI: 10.1371/journal.pone.0273302] [Reference Citation Analysis]
25 Kamis KF, Wyles DL, Minturn MS, Scott T, McEwen D, Hurley H, Prendergast SJ, Gunter J, Rowan SE. A retrospective, descriptive study of hepatitis C testing, prevalence, and care continuum among adults on probation. Health Justice 2022;10:26. [PMID: 35947313 DOI: 10.1186/s40352-022-00191-9] [Reference Citation Analysis]
26 Eckhardt B, Aponte-Melendez Y, Kapadia SN, Mateu-Gelabert P. Contact tracing in acute hepatitis C: The source patient identification and group overlap therapy proof-of-concept pilot program. Clin Liver Dis (Hoboken) 2022;20:72-6. [PMID: 36033428 DOI: 10.1002/cld.1242] [Reference Citation Analysis]
27 Ross AJ, Ross BJ, Lee OC, Williams GH, Savoie FH, O’brien MJ, Sanchez FL, Sherman WF. Does Pre-Arthroplasty Antiviral Treatment for Hepatitis C Reduce Complication Rates After Total Shoulder Arthroplasty? A Matched Cohort Study. JSES International 2022. [DOI: 10.1016/j.jseint.2022.07.012] [Reference Citation Analysis]
28 Calcaterra SL, Martin M, Bottner R, Englander H, Weinstein Z, Weimer MB, Lambert E, Herzig SJ. Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine. J Hosp Med 2022. [PMID: 35880813 DOI: 10.1002/jhm.12893] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Honegger JR, Gowda C. Defer no more: advances in the treatment and prevention of chronic hepatitis C virus infection in children. Curr Opin Infect Dis 2022. [PMID: 35852787 DOI: 10.1097/QCO.0000000000000856] [Reference Citation Analysis]
30 Khan MA, Thompson WW, Osinubi A, Meyer 3rd WA, Kaufman HW, Armstrong PA, Foster MA, Nelson NP, Wester C. Trends in testing for hepatitis C during pregnancy among persons with Medicaid and commercial insurance, 2015–2019 (Preprint).. [DOI: 10.2196/preprints.40783] [Reference Citation Analysis]
31 Kaufman HW, Osinubi A, Meyer WA, Khan M, Huang X, Panagiotakopoulos L, Thompson WW, Nelson N, Wester C. Hepatitis C Virus Testing During Pregnancy After Universal Screening Recommendations. Obstetrics & Gynecology 2022;140:99-101. [DOI: 10.1097/aog.0000000000004822] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Harless C, Lugo B, Ostrach B. Hepatitis C and HIV Screening, Testing, and Risk Perceptions among South-Central Appalachian County Health Department Staff. South Med J 2022;115:422-8. [PMID: 35777748 DOI: 10.14423/SMJ.0000000000001409] [Reference Citation Analysis]
33 Carty PG, Teljeur C, De Gascun CF, Gillespie P, Harrington P, McCormick A, O'Neill M, Smith SM, Ryan M. Another Step Toward Hepatitis C Elimination: An Economic Evaluation of an Irish National Birth Cohort Testing Program. Value Health 2022:S1098-3015(22)01998-2. [PMID: 35778325 DOI: 10.1016/j.jval.2022.05.010] [Reference Citation Analysis]
34 Laperche S, Caparros R, Kankarafou N, Lucas Q, Boizeau L. Comparative evaluation of the Geenius HCV supplemental assay and Inno-LIA HCV score assay in detecting anti-HCV antibodies. Transfus Clin Biol 2022:S1246-7820(22)00067-2. [PMID: 35728751 DOI: 10.1016/j.tracli.2022.06.005] [Reference Citation Analysis]
35 Brelje A, Fay B, Mariouw S, Vandenberg A. Identifying olanzapine induced liver injury in the setting of acute hepatitis C: A case report. Mental Health Clinician 2022;12:210-3. [DOI: 10.9740/mhc.2022.06.210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Prabhu M, Riley LE. Challenges in Interpreting the Ob/Gyn Literature: Studies of Screening. Clin Obstet Gynecol 2022;65:244-51. [PMID: 35354158 DOI: 10.1097/GRF.0000000000000704] [Reference Citation Analysis]
37 Terlapu PV, Gedela SB, Gangu VK, Pemula R. Intelligent diagnosis system of hepatitis C virus: A probabilistic neural network based approach. Int J Imaging Syst Tech. [DOI: 10.1002/ima.22746] [Reference Citation Analysis]
38 Lyzwinski LN, Naslund JA, Miller CJ, Eisenberg MJ. Global youth vaping and respiratory health: epidemiology, interventions, and policies. npj Prim Care Respir Med 2022;32. [DOI: 10.1038/s41533-022-00277-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
39 Ades AE, Gordon F, Scott K, Collins IJ, Thorne C, Pembrey L, Chappell E, Mariné-Barjoan E, Butler K, Indolfi G, Gibb DM, Judd A. Spontaneous Clearance Of Vertically Acquired Hepatitis C Infection: Implications For Testing And Treatment. Clin Infect Dis 2022:ciac255. [PMID: 35396848 DOI: 10.1093/cid/ciac255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Curry K, Chandler R, Kostas-Polston EA, Alexander I, Orsega S, Johnson-Mallard V. Recommendations for managing sexually transmitted infections: Incorporating the 2021 guidelines. Nurse Pract 2022;47:10-8. [PMID: 35349512 DOI: 10.1097/01.NPR.0000822528.27483.b2] [Reference Citation Analysis]
41 Nagra N, Kozarek RA, Burman BE. Therapeutic Advances in Viral Hepatitis A-E. Adv Ther 2022;39:1524-52. [PMID: 35220557 DOI: 10.1007/s12325-022-02070-z] [Reference Citation Analysis]
42 Fartushna OY, Prokopiv MM, Krylova VY, Rohoza SV, Palahuta HV, Hnepa YY, Fartushnyi YM. ASEPTIC MENINGITIS AS AN EXTRAHEPATIC MANIFESTATION OF HEPATITIS C: A CLINICAL CASE PRESENTATIONIN A WHITE YOUNG FEMALE EUROPEAN ADULT. Wiad Lek 2022;75:1043-1046. [DOI: 10.36740/wlek20220420123] [Reference Citation Analysis]
43 Kislovskiy Y, Chappell C, Flaherty E, Hamm ME, de Abril Cameron F, Krans E, Chang JC. Motives and risk perceptions of participants in a phase 1 trial for Hepatitis C Virus investigational therapy in pregnancy. Research Ethics 2022;18:132-150. [DOI: 10.1177/17470161211066159] [Reference Citation Analysis]
44 Hrydina T. PECULIARITIES OF TREATMENT AND PREVENTION OF INFECTION CAUSED BY HEPATITIS C VIRUS. Review. Med Sci of Ukr 2022;18:64-72. [DOI: 10.32345/2664-4738.1.2022.09] [Reference Citation Analysis]
45 Moradi G, Soheili M, Rashti R, Dehghanbanadaki H, Nouri E, Zakaryaei F, Amini EE, Baiezeedi S, Ahmadi S, Moradi Y. The prevalence of hepatitis C and hepatitis B in lesbian, gay, bisexual and transgender populations: a systematic review and meta-analysis. Eur J Med Res 2022;27:47. [PMID: 35346371 DOI: 10.1186/s40001-022-00677-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Biondi MJ, Hirode G, Capraru C, Vanderhoff A, Karkada J, Wolfson-stofko B, Smookler D, Friedman SM, Bates K, Mazzulli T, Juan JV, Shah H, Hansen BE, Feld JJ, Janssen HL. Birth cohort hepatitis C antibody prevalence in real-world screening settings in Ontario. CanLivJ. [DOI: 10.3138/canlivj-2021-0036] [Reference Citation Analysis]
47 Eckhardt B, Mateu-Gelabert P, Aponte-Melendez Y, Fong C, Kapadia S, Smith M, Edlin BR, Marks KM. Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial. JAMA Intern Med 2022. [PMID: 35285851 DOI: 10.1001/jamainternmed.2022.0170] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
48 Hoff E, Warden A, Taylor R, Nijhawan AE. Hepatitis C Epidemiology in a Large Urban Jail: A Changing Demographic. Public Health Rep 2022;:333549221076546. [PMID: 35238249 DOI: 10.1177/00333549221076546] [Reference Citation Analysis]
49 Ross AJ, Ross BJ, Lee OC, Hood HW, Sanchez FL, Sherman WF. Does Preoperative Antiviral Treatment for Hepatitis C Decrease Risk of Complications After Total Hip Arthroplasty? A Matched Cohort Study. J Arthroplasty 2022:S0883-5403(22)00253-4. [PMID: 35248753 DOI: 10.1016/j.arth.2022.02.102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Hoenigl M, Abramovitz D, Flores Ortega RE, Martin NK, Reau N. Sustained impact of the COVID-2019 pandemic on HCV treatment initiations in the United States. Clin Infect Dis 2022:ciac175. [PMID: 35234860 DOI: 10.1093/cid/ciac175] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Dionne-Odom J, Cozzi GD, Franco RA, Njei B, Tita ATN. Treatment and prevention of viral hepatitis in pregnancy. Am J Obstet Gynecol 2022;226:335-46. [PMID: 34516961 DOI: 10.1016/j.ajog.2021.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
52 Mehta SJ, Torgersen J, Small DS, Mallozzi CP, McGreevey JD 3rd, Rareshide CAL, Evans CN, Epps M, Stabile D, Snider CK, Patel MS. Effect of a Default Order vs an Alert in the Electronic Health Record on Hepatitis C Virus Screening Among Hospitalized Patients: A Stepped-Wedge Randomized Clinical Trial. JAMA Netw Open 2022;5:e222427. [PMID: 35297973 DOI: 10.1001/jamanetworkopen.2022.2427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Mercan Başpınar M, Kasapcopur O. Screening of Hepatitis A and B Seropositivity among Turkish Healthcare Providers Admitted to Occupational Health Services. International Journal of Clinical Practice 2022;2022:1-8. [DOI: 10.1155/2022/6065335] [Reference Citation Analysis]
54 Teshale EH, Roberts H, Gupta N, Jiles R. Characteristics of persons treated for hepatitis C using national pharmacy claims data, United States, 2014-2020. Clin Infect Dis 2022:ciac139. [PMID: 35171997 DOI: 10.1093/cid/ciac139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Cave B, Serper M, Box T, Ramers C, Stainbrook T, Reau N, Trooskin S, Sulkowski M, Dieterich D, Dinani A. A simplified algorithm for managing hepatitis C infection by leveraging telemedicine. GHOA 2022;13:12-20. [DOI: 10.15406/ghoa.2022.13.00488] [Reference Citation Analysis]
56 Bargad A, Vogtschaller H. Laboratory Screening and Diagnostic Testing in Antepartum Care. Pediatric Diagnostic Labs for Primary Care: An Evidence-based Approach 2022. [DOI: 10.1007/978-3-030-90642-9_2] [Reference Citation Analysis]
57 Thomas MD, Vittinghoff E, Crystal S, Walkup J, Olfson M, Khalili M, Dahiya P, Keenan W, Cournos F, Mangurian C. Hepatitis C Screening Among Medicaid Patients With Schizophrenia, 2002-2012. Schizophr Bull Open 2022;3:sgab058. [PMID: 35059641 DOI: 10.1093/schizbullopen/sgab058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Nagami EH, Rich JD, Lee JD. Screening for Public Purpose: Promoting an Evidence-Based Approach to Screening of Inmates to Improve Public Health. Public Health Behind Bars 2022. [DOI: 10.1007/978-1-0716-1807-3_15] [Reference Citation Analysis]
59 Ye Q, Kam LY, Yeo YH, Dang N, Huang DQ, Cheung R, Nguyen MH. Substantial gaps in evaluation and treatment of patients with hepatitis B in the US. J Hepatol 2022;76:63-74. [PMID: 34474097 DOI: 10.1016/j.jhep.2021.08.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
60 Bs RM, Wong K, Naylor P, Ehrinpreis M, Mutchnick M. Racial disparity in age and genotype defines urban hepatitis C patient profiles in the recent direct-acting antiviral era. GHOA 2021;12:190-197. [DOI: 10.15406/ghoa.2021.12.00485] [Reference Citation Analysis]
61 Behnke C, Nissim O, Simerlein W, Beeker K, Tarleton JL, Lazenby GB. Quality improvement to evaluate and provide treatment for chronic hepatitis C postpartum. J Am Pharm Assoc (2003) 2021:S1544-3191(21)00553-7. [PMID: 34975005 DOI: 10.1016/j.japh.2021.12.006] [Reference Citation Analysis]
62 Groves JA, Y Dodd R, Zhu X, Linnen JM, Stramer SL. Background rate of low-level HCV RNA in anti-HCV confirmed-positive and minipool nucleic acid test-nonreactive blood donations. Transfusion 2021. [PMID: 34888879 DOI: 10.1111/trf.16759] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Kaplan A, Brown RS. HCV and Liver Transplantation. Curr Hepatology Rep 2021;20:191-197. [DOI: 10.1007/s11901-021-00580-y] [Reference Citation Analysis]
64 Dowling-mcclay K, Mathis SM, Hagemeier N. Community pharmacist engagement in HIV and HCV prevention: Current practices and potential for service uptake. Exploratory Research in Clinical and Social Pharmacy 2021;4:100088. [DOI: 10.1016/j.rcsop.2021.100088] [Reference Citation Analysis]
65 Morris KE, Muir AJ. Care After Cure: Long-term Follow-up in Hepatitis C. Curr Hepatology Rep 2021;20:183-190. [DOI: 10.1007/s11901-021-00579-5] [Reference Citation Analysis]
66 Moradi G, Alavian SM, Gholami F, Ramezani R, Ahangarzadeh L, Moradi Y, Sharafi H. Prevalence of Hepatitis B and Hepatitis C Infections among Incarcerated Individuals in Iran: A Cross-Sectional National Bio-behavioral Study in 2019. Pathogens 2021;10:1522. [PMID: 34832678 DOI: 10.3390/pathogens10111522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Ouoba S, Ouedraogo JCRP, Lingani M, E B, Hussain MRA, Ko K, Nagashima S, Sugiyama A, Akita T, Tinto H, Tanaka J. Epidemiologic profile of hepatitis C virus infection and genotype distribution in Burkina Faso: a systematic review with meta-analysis. BMC Infect Dis 2021;21:1126. [PMID: 34724902 DOI: 10.1186/s12879-021-06817-x] [Reference Citation Analysis]
68 Parikh BA. Laboratory Strategies for Diagnosis and Monitoring of Hepatis C Virus Infection. Clinical Microbiology Newsletter 2021;43:193-203. [DOI: 10.1016/j.clinmicnews.2021.11.001] [Reference Citation Analysis]
69 Pro G, Tompkins DA, Azari S, Zaller N. National trends in testing for hepatitis C virus in licensed opioid treatment programs: Differences by facility ownership and state medicaid expansion status. Drug Alcohol Depend 2021;228:109092. [PMID: 34571287 DOI: 10.1016/j.drugalcdep.2021.109092] [Reference Citation Analysis]
70 McCormick CA, Domegan L, Carty PG, Drew R, McAuliffe FM, O'Donohoe O, White N, Garvey P, O'Grady M, De Gascun CF, McCormick PA. Routine screening for hepatitis C in pregnancy is cost-effective in a large urban population in Ireland: a retrospective study. BJOG 2022;129:322-7. [PMID: 34706147 DOI: 10.1111/1471-0528.16984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
71 Granozzi B, Guardigni V, Badia L, Rosselli Del Turco E, Zuppiroli A, Tazza B, Malosso P, Pieralli S, Viale P, Verucchi G. Out-of-Hospital Treatment of Hepatitis C Increases Retention in Care among People Who Inject Drugs and Homeless Persons: An Observational Study. J Clin Med 2021;10:4955. [PMID: 34768474 DOI: 10.3390/jcm10214955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Jonas MC, Rubenstein K, Watson E, Basra S, Horberg M. A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States. Viruses 2021;13:2140. [PMID: 34834947 DOI: 10.3390/v13112140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Afaneh H, Straif-Bourgeois S, Oral E, Wennerstrom A, Sugarman O, Robinson WT, Whittington A, Trapido E. Louisiana Medicaid access for treatment and care for hepatitis C virus (LA-MATCH) project: A cross-sectional study protocol. PLoS One 2021;16:e0257437. [PMID: 34613969 DOI: 10.1371/journal.pone.0257437] [Reference Citation Analysis]
74 Kislovskiy Y, Chappell C, Flaherty E, Hamm ME, Cameron FA, Krans EE, Chang JC. Experiences and Perspectives From Women Taking Investigational Therapy for Hepatitis C Virus During Pregnancy. Subst Abuse 2021;15:11782218211046261. [PMID: 34602820 DOI: 10.1177/11782218211046261] [Reference Citation Analysis]
75 Gill M, Sharafat J, Ikram F, Ul Qamar M, Rehman I, Saleem M, Noreen A, Khadim N, Horii A, Tahir B. Correlation Between Serum Ferritin and Hepcidin Levels in Chronic Hepatitis C Patients. Cureus 2021;13:e17484. [PMID: 34603871 DOI: 10.7759/cureus.17484] [Reference Citation Analysis]
76 King H, Soh JE, Thompson WW, Brown JR, Rapposelli K, Vellozzi C. Testing for Hepatitis C Virus Infection Among Adults Aged ≥18 in the United States, 2013-2017. Public Health Rep 2021;:333549211047236. [PMID: 34606398 DOI: 10.1177/00333549211047236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Rihan F, Arafa A, Rakkiyappan R, Rajivganthi C, Xu Y. Fractional-order delay differential equations for the dynamics of hepatitis C virus infection with IFN- α treatment. Alexandria Engineering Journal 2021;60:4761-74. [DOI: 10.1016/j.aej.2021.03.057] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
78 Guntipalli P, Pakala R, Kumari Gara S, Ahmed F, Bhatnagar A, Endaya Coronel MK, Razzack AA, Solimando AG, Thompson A, Andrews K, Enebong Nya G, Ahmad S, Ranaldo R, Cozzolongo R, Shahini E. Worldwide prevalence, genotype distribution and management of hepatitis C. Acta Gastroenterol Belg 2021;84:637-56. [PMID: 34965046 DOI: 10.51821/84.4.015] [Reference Citation Analysis]
79 Foley E, Breit S, Marsh C, Ault K, Lydic M. Attitudes toward Rubella and Varicella Vaccination during Preconception Care. Kans J Med 2021;14:215-9. [PMID: 34540135 DOI: 10.17161/kjm.vol1415205] [Reference Citation Analysis]
80 Ajao S, Roach D, Chan KH, Thimmanagari K, Muhanna A, Mutyala M, Lakasanni S, Slim J. The Roles of Fibrosis Index Based on Four Factors and Aspartate Transaminase-to-Platelet Ratio Index Scoring Systems as an Alternative to Transient Elastography Liver Stiffness in Liver Fibrosis Staging in Human Immunodeficiency Virus and Hepatitis C Virus Co-Infected Patients. Gastroenterology Res 2021;14:209-13. [PMID: 34527089 DOI: 10.14740/gr1377] [Reference Citation Analysis]
81 Epstein RL, Moloney C, Garfinkel J, Saia K, Wachman EM, Lodi S, Pelton SI. Enhancing Linkage to Hepatitis C Virus Treatment Following Pregnancy in Women Identified During Perinatal Care. Hepatol Commun 2021;5:1543-54. [PMID: 34510828 DOI: 10.1002/hep4.1748] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
82 Rana R, Dangal R, Singh Y, Gurung RB, Rai B, Sharma AK. Hepatitis C Virus Infection in Pregnancy and Children: Its Implications and Treatment Considerations with Directly Acting Antivirals: A Review. JNMA J Nepal Med Assoc 2021;59:942-53. [PMID: 35199739 DOI: 10.31729/jnma.5501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Sanghi V, Lindenmeyer CC. Viral Hepatitis in Pregnancy: An Update on Screening, Diagnosis, and Management. Clin Liver Dis (Hoboken) 2021;18:7-13. [PMID: 34484697 DOI: 10.1002/cld.1079] [Reference Citation Analysis]
84 Jose R, Kahal D, Testa K, Goldstein ND; MBI4. A Qualitative Study of Implementing Universal Hepatitis C Screening Among Adults at an Urban Community-Based Health Provider in Delaware. Dela J Public Health 2021;7:16-23. [PMID: 34467206 DOI: 10.32481/djph.2021.07.006] [Reference Citation Analysis]
85 Dotters-Katz SK, Kuller JA, Hughes BL; Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org. Society for Maternal-Fetal Medicine Consult Series #56: Hepatitis C in pregnancy-updated guidelines: Replaces Consult Number 43, November 2017. Am J Obstet Gynecol 2021;225:B8-B18. [PMID: 34116035 DOI: 10.1016/j.ajog.2021.06.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
86 Bushman ET, Subramani L, Sanjanwala A, Dionne-Odom J, Franco R, Owen J, Subramaniam A. Pragmatic Experience with Risk-based versus Universal Hepatitis C Screening in Pregnancy: Detection of Infection and Postpartum Linkage to Care. Am J Perinatol 2021;38:1109-16. [PMID: 33934324 DOI: 10.1055/s-0041-1728827] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 Dunham K, McDonald J, Yousaf A, Barocas JA, Neill M, Noska A, Flanigan TP. Healthcare Providers' Views on Hepatitis C Testing and Counseling Among Sexual Partners of Hepatitis-C-Infected Persons: An Online Survey. Infect Dis Clin Pract (Baltim Md) 2021;29:e151-3. [PMID: 34447237 DOI: 10.1097/ipc.0000000000000950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Kamara MTB, Richards VL, Somboonwit C, Park H, Seneadza NAH, Zhi Z, Jayaweera D, Thomas E, Cook RL. Self-reported hepatitis C(HCV) testing among people living with human immunodeficiency virus (PLWH). Heliyon 2021;7:e07727. [PMID: 34409188 DOI: 10.1016/j.heliyon.2021.e07727] [Reference Citation Analysis]
89 Bush AM, Deegan C, Gleeson T. Viral Hepatitis C-Related Care in Active Duty and Reserve Service Members: A Retrospective Review. Mil Med 2021:usab340. [PMID: 34387685 DOI: 10.1093/milmed/usab340] [Reference Citation Analysis]
90 Harris AM, Khan MA, Osinubi A, Nelson NP, Thompson WW. Hepatitis C Treatment Among Commercially or Medicaid-Insured Individuals, 2014-2018. Am J Prev Med 2021:S0749-3797(21)00348-2. [PMID: 34362617 DOI: 10.1016/j.amepre.2021.05.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
91 Sowah L, Chiou C. Impact of Coronavirus Disease 2019 Pandemic on Viral Hepatitis Elimination: What Is the Price? AIDS Res Hum Retroviruses 2021;37:585-8. [PMID: 33913731 DOI: 10.1089/AID.2020.0301] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
92 Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70:1-187. [PMID: 34292926 DOI: 10.15585/mmwr.rr7004a1] [Cited by in Crossref: 231] [Cited by in F6Publishing: 239] [Article Influence: 231.0] [Reference Citation Analysis]
93 Perkins M, Slevin A, Strand MA, Freisner D. Screening at a Federally Qualified Health Center in the Midwest for Hepatitis C Among People Who Inject Drugs, 2019-2020. Prev Chronic Dis 2021;18:E69. [PMID: 34264813 DOI: 10.5888/pcd18.200604] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Eleje GU, Rabiu A, Mbachu II, Akaba GO, Loto OM, Usman HA, Fiebai PO, Chukwuanukwu RC, Joe-Ikechebelu NN, Nwankwo CH, Kalu SO, Onubogu CU, Ogbuagu CN, Chukwurah SN, Uzochukwu CE, Inuyomi SO, Adesoji BA, Ogwaluonye UC, Emeka EA, Egeonu RO, Igue OE, Jibuaku CH, Okoro OD, Aja PO, Chidozie CP, Ibrahim HS, Aliyu FE, Numan AI, Omoruyi SA, Oppah IC, Anyang UI, Ahmed A, Umeononihu OS, Umeh EO, Nweje SI, Ajuba IC, Okoro CC, Onwuegbuna AA, Igbodike EP, Nwaeju IK, Yakasai IA, Ezechi OC, Ikechebelu JI. Awareness and prevalence of hepatitis C virus infection among pregnant women in Nigeria: A national pilot cross-sectional study. Womens Health (Lond) 2021;17:17455065211031718. [PMID: 34256625 DOI: 10.1177/17455065211031718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Shahid I, Alzahrani AR, Al-Ghamdi SS, Alanazi IM, Rehman S, Hassan S. Hepatitis C Diagnosis: Simplified Solutions, Predictive Barriers, and Future Promises. Diagnostics (Basel) 2021;11:1253. [PMID: 34359335 DOI: 10.3390/diagnostics11071253] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
96 Jiang X, Parker RL, Vouri SM, Lo-Ciganic W, Diaby V, Henry L, Park H. Cascade of Hepatitis C Virus Care Among Patients With Substance Use Disorders. Am J Prev Med 2021:S0749-3797(21)00271-3. [PMID: 34210584 DOI: 10.1016/j.amepre.2021.04.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Park JS, Wong J, Cohen H. Hepatitis C virus screening of high-risk patients in a community hospital emergency department: Retrospective review of patient characteristics and future implications. PLoS One 2021;16:e0252976. [PMID: 34111200 DOI: 10.1371/journal.pone.0252976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
98 Wynn A, Tweeten S, McDonald E, Wooten W, Lucas K, Cyr CL, Hernandez M, Ramirez F, VanWormer C, Suckow S, Ramers CB, Martin NK. The estimated hepatitis C seroprevalence and key population sizes in San Diego in 2018. PLoS One 2021;16:e0251635. [PMID: 34106932 DOI: 10.1371/journal.pone.0251635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Epstein RL, Espinosa C. Hepatitis C Virus in Neonates and Infants. Clin Perinatol 2021;48:343-57. [PMID: 34030818 DOI: 10.1016/j.clp.2021.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Burrell CN, Sharon MJ, Davis S, Feinberg J, Wojcik EM, Nist J, Lander O, Boley V, Burns J, Martin IBK. Using the electronic medical record to increase testing for HIV and hepatitis C virus in an Appalachian emergency department. BMC Health Serv Res 2021;21:524. [PMID: 34051774 DOI: 10.1186/s12913-021-06482-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 Surana P, Hercun J, Takyar V, Kleiner DE, Heller T, Koh C. Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis. World J Gastrointest Pathophysiol 2021; 12(3): 40-50 [PMID: 34084591 DOI: 10.4291/wjgp.v12.i3.40] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
102 Duarte G, Pezzuto P, Barros TD, Mosimann Junior G, Martinez-Espinosa FE. Brazilian Protocol for Sexually Transmitted Infections 2020: viral hepatitis. Rev Soc Bras Med Trop 2021;54:e2020834. [PMID: 34008732 DOI: 10.1590/0037-8682-834-2020] [Reference Citation Analysis]
103 Ford JS, Chechi T, Toosi K, Mahmood B, Meehleis D, Otmar M, Tran N, May L. Universal Screening for Hepatitis C Virus in the ED Using a Best Practice Advisory. West J Emerg Med 2021;22:719-25. [PMID: 34125052 DOI: 10.5811/westjem.2021.1.49667] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
104 Kaufman HW, Bull-Otterson L, Meyer WA 3rd, Huang X, Doshani M, Thompson WW, Osinubi A, Khan MA, Harris AM, Gupta N, Van Handel M, Wester C, Mermin J, Nelson NP. Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic. Am J Prev Med 2021;61:369-76. [PMID: 34088556 DOI: 10.1016/j.amepre.2021.03.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 16.0] [Reference Citation Analysis]
105 Mari PC, Gulati R, Fragassi P. Adolescent Hepatitis C: Prevalence, Impact, and Management Challenges. Adolesc Health Med Ther 2021;12:45-53. [PMID: 33994820 DOI: 10.2147/AHMT.S263864] [Reference Citation Analysis]
106 Feld JJ, Ward JW. Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020. Hepatol Commun 2021;5:911-22. [PMID: 34141979 DOI: 10.1002/hep4.1731] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
107 Kilmer GA, Ly KN, Moorman AC. Health Insurance Status of Adults with Hepatitis in the United States: Implications of Results from the National Health Interview Survey, 2013-2018. Popul Health Manag 2021. [PMID: 33909456 DOI: 10.1089/pop.2021.0053] [Reference Citation Analysis]
108 Huang Y, Pan H, Gao Q, Lv P, Xu X, Zhao Z. The role of a two-assay serological testing strategy for anti-HCV screening in low-prevalence populations. Sci Rep 2021;11:8689. [PMID: 33888806 DOI: 10.1038/s41598-021-88138-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
109 Bailey AL, Al-Adwan S, Sneij E, Campbell N, Wiisanen ME. Atherosclerotic Cardiovascular Disease in Individuals with Hepatitis C Viral Infection. Curr Cardiol Rep 2021;23:52. [PMID: 33822282 DOI: 10.1007/s11886-021-01475-6] [Reference Citation Analysis]
110 Busschots D, Arain A, Bielen R, Koc ÖM, Bruckers L, Rakhmawati T, Corten K, Lebbe C, Cornelis K, Mathei C, Buntinx F, Hens N, Robaeys G. Uptake of hepatitis C virus screening and treatment in persons under opioid substitution therapy between 2008 and 2013 in Belgium. Acta Gastroenterol Belg 2021;84:311-6. [PMID: 34217181 DOI: 10.51821/84.2.311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Chappell CA, Jonas MM. Hepatitis C Virus in Pregnancy: Are We Ready for Test and Treat? J Infect Dis 2020;222:S789-93. [PMID: 33245353 DOI: 10.1093/infdis/jiaa181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
112 Levitt A, Mermin J, Jones CM, See I, Butler JC. Infectious Diseases and Injection Drug Use: Public Health Burden and Response. J Infect Dis 2020;222:S213-7. [PMID: 32877539 DOI: 10.1093/infdis/jiaa432] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
113 Duarte G, Pezzuto P, Barros TD, Mosimann Junior G, Martínez-Espinosa FE. [Brazilian Protocol for Sexually Transmitted Infections 2020: viral hepatitis]. Epidemiol Serv Saude 2021;30:e2020834. [PMID: 33729415 DOI: 10.1590/S1679-4974202100016.esp1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
114 Lazarus JV, Picchio CA, Guy D, Aleman S, James C, Nava FA, Øvrehus A, Turnes J, Ward JW, Ustianowski A. Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy. Clin Res Hepatol Gastroenterol 2021;45:101564. [PMID: 33740477 DOI: 10.1016/j.clinre.2020.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
115 Faure-Bardon V, Ville Y. Maternal infections: revisiting the need for screening in pregnancy. BJOG 2021;128:304-15. [PMID: 32937015 DOI: 10.1111/1471-0528.16509] [Reference Citation Analysis]
116 Kushner T, Reau N. Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy. J Hepatol 2021;74:734-41. [PMID: 33248169 DOI: 10.1016/j.jhep.2020.11.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
117 Sert UY, Engin-ustun Y, Saygan S, Ozgu-erdinc AS. Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Status in the Pregnancy. Infect Dis Clin Pract 2021;29:e97-e100. [DOI: 10.1097/ipc.0000000000000951] [Reference Citation Analysis]
118 Yang N, Muir A. Coordination, Cost, and Changing Epidemiology-Considerations in the Hepatitis C Care Cascade. Hepatol Commun 2021;5:355-7. [PMID: 33681671 DOI: 10.1002/hep4.1667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Ahrens KA, Rossen LM, Burgess AR, Palmsten KK, Ziller EC. Rural-Urban Residence and Maternal Hepatitis C Infection, U.S.: 2010-2018. Am J Prev Med 2021;60:820-30. [PMID: 33640230 DOI: 10.1016/j.amepre.2020.12.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
120 Rogan SC, Beigi RH. Management of Viral Complications of Pregnancy: Pharmacotherapy to Reduce Vertical Transmission. Obstet Gynecol Clin North Am 2021;48:53-74. [PMID: 33573790 DOI: 10.1016/j.ogc.2020.12.001] [Reference Citation Analysis]
121 Gatta LA, Hughes BL. Premature Rupture of Membranes with Concurrent Viral Infection. Obstet Gynecol Clin North Am 2020;47:605-23. [PMID: 33121648 DOI: 10.1016/j.ogc.2020.08.006] [Reference Citation Analysis]
122 Godar EA, Jhaveri R. A Survey of Practices in the United States Regarding Hepatitis C Screening in Pregnant Women. Clin Ther 2021;43:780-4. [PMID: 33558077 DOI: 10.1016/j.clinthera.2021.01.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Silva JPCG, Jesus LS, Isabel Schinoni M, Oliveira IS, Atta MLBS, Atta AM. IgE antibodies to hepatitis C virus core and nonstructural antigens in chronic hepatitis C patients before and after antiviral treatment. Int Immunopharmacol 2021;93:107405. [PMID: 33529909 DOI: 10.1016/j.intimp.2021.107405] [Reference Citation Analysis]
124 Judd A, Collins IJ, Pett S, Gibb DM. Labour pains: eliminating HCV in women and children. Lancet Gastroenterol Hepatol 2021;6:150-1. [PMID: 33515495 DOI: 10.1016/S2468-1253(20)30373-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
125 Prince HE, Marlowe EM, Schwab DS. Relationship between hepatitis C virus (HCV) IgG index values and quantitative HCV RNA results in HCV IgG-reactive serum samples. Diagn Microbiol Infect Dis 2021;100:115311. [PMID: 33524728 DOI: 10.1016/j.diagmicrobio.2021.115311] [Reference Citation Analysis]
126 Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7-33. [PMID: 33433946 DOI: 10.3322/caac.21654] [Cited by in Crossref: 6065] [Cited by in F6Publishing: 6715] [Article Influence: 6065.0] [Reference Citation Analysis]
127 Wang S, Cohen C, Tang AS, Graham CS. Hepatitis B Virus Elimination in the U.S.: Time to Dismantle Barriers and Implement Solutions. Curr Hepatology Rep 2021;20:34-42. [DOI: 10.1007/s11901-020-00557-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
128 Pericot-valverde I, Ahuja D, Norton BL, Litwin AH. Opioid use disorder and HCV (hepatitis C virus). The Opioid Epidemic and Infectious Diseases 2021. [DOI: 10.1016/b978-0-323-68328-9.00006-0] [Reference Citation Analysis]
129 Sulkowski M, Cheng WH, Marx S, Sanchez Gonzalez Y, Strezewski J, Reau N. Estimating the Year Each State in the United States Will Achieve the World Health Organization's Elimination Targets for Hepatitis C. Adv Ther 2021;38:423-40. [PMID: 33145648 DOI: 10.1007/s12325-020-01535-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
130 Pearce ME, Yu A, Alvarez M, Bartlett SR, Binka M, Jeong D, Clementi E, Adu P, Wilton J, Yoshida EM, Pick N, Buxton JA, Wong J, Jassem A, Krajden M, Janjua NZ. Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008-2019. PLoS One 2020;15:e0244575. [PMID: 33382774 DOI: 10.1371/journal.pone.0244575] [Reference Citation Analysis]
131 Choi S, Healy S, Shapoval L, Forthal S, Neighbors CJ. Hepatitis C Virus Screening among Medicaid-Insured Individuals with Opioid Use Disorder across Substance Use Disorder Treatment Settings. Subst Use Misuse 2021;56:258-63. [PMID: 33345680 DOI: 10.1080/10826084.2020.1858106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
132 Sperring H, Ruiz-Mercado G, Schechter-Perkins EM. Impact of the 2020 COVID-19 Pandemic on Ambulatory Hepatitis C Testing. J Prim Care Community Health. 2020;11:2150132720969554. [PMID: 33225792 DOI: 10.1177/2150132720969554] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
133 Patel AA, Bui A, Prohl E, Bhattacharya D, Wang S, Branch AD, Perumalswami PV. Innovations in Hepatitis C Screening and Treatment. Hepatol Commun 2021;5:371-86. [PMID: 33681673 DOI: 10.1002/hep4.1646] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
134 Mera J, Williams MB, Essex W, McGrew KM, Boeckman L, Gahn D, Miller A, Durham D, Fox J, David C, Ritter T, Jones S, Bouse S, Galvani A, Ward JW, Drevets DA, Carabin H. Evaluation of the Cherokee Nation Hepatitis C Virus Elimination Program in the First 22 Months of Implementation. JAMA Netw Open 2020;3:e2030427. [PMID: 33337496 DOI: 10.1001/jamanetworkopen.2020.30427] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
135 Krinsky DL. Chapter 48: Home Testing and Monitoring Devices. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 20th Edition 2020. [DOI: 10.21019/9781582123172.ch48] [Reference Citation Analysis]
136 Spradling PR, Zhong Y, Moorman AC, Rupp LB, Lu M, Gordon SC, Teshale EH, Schmidt MA, Daida YG, Boscarino JA; Chronic Hepatitis Cohort Study (CHeCS) Investigators. Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of Cure. Hepatol Commun 2021;5:400-11. [PMID: 33681675 DOI: 10.1002/hep4.1632] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
137 Leach M, Chapin S, Porges I, Portner S, Charest T, Downing J, Weinstein LC. Evaluation of Risk Factors for Hepatitis C Virus Infection Among Philadelphia's Shelter-Bound, Homeless Population: Data from a Student-Run Hepatitis C Virus Screening Initiative. Popul Health Manag 2021;24:448-53. [PMID: 33252303 DOI: 10.1089/pop.2020.0143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
138 Cowan EA, Dinani A, Brandspiegel S, O'Brien-Lambert C, Zaheer J, Eiting E, Loo G, Calderon Y. Nontargeted Hepatitis C Screening in an Urban Emergency Department in New York City. J Emerg Med 2021;60:299-309. [PMID: 33213988 DOI: 10.1016/j.jemermed.2020.09.034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
139 Egerman RS, Wen TS. Hepatitis C Virus Antibody Screening in a Cohort of Pregnant Women: Identifying Seroprevalence and Risk Factors. Obstet Gynecol 2020;136:427. [PMID: 32732756 DOI: 10.1097/AOG.0000000000004031] [Reference Citation Analysis]
140 Kushner T, Park C, Masand D, Wagner B, Grace M, Rosenbluth E, Rodriquez-Rivas C, de la Cruz H, Overbey J, Sperling R. Hepatitis C Seroprevalence Among Consecutive Labor and Delivery Admissions in Two New York City Hospitals. Open Forum Infect Dis 2020;7:ofaa514. [PMID: 33241070 DOI: 10.1093/ofid/ofaa514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
141 Story MT, Sanders ML, Bashir AA, Longo JM, Abel SL, Dollard SC, Grodstein EI, Thomas CP, Katz DA. Infiltrating Kaposi sarcoma presenting as acute kidney injury: An unexpected consequence of deliberate hepatitis C-positive organ transplantation. Transpl Infect Dis 2021;23:e13481. [PMID: 33012057 DOI: 10.1111/tid.13481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
142 Habchi J, Thomas AM, Sprecht-Walsh S, Arias E, Bratberg J, Hurley L, Hart S, Taylor LE. Optimizing Hepatitis C Virus (HCV) Treatment in a US Colocated HCV/Opioid Agonist Therapy Program. Open Forum Infect Dis 2020;7:ofaa310. [PMID: 33072802 DOI: 10.1093/ofid/ofaa310] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
143 Elahi W, Syed AZ, Nasim F, Anwar A, Hashmi AA. Hepatitis B and C Infections in Patients With Prolonged Hemodialysis Secondary to Chronic Renal Failure. Cureus 2020;12:e10905. [PMID: 33194472 DOI: 10.7759/cureus.10905] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
144 Watts T, Lauver D, Sethi AK, Snedden T, Zahner S. Hepatitis C virus infections among people aged 15-44, United States, 2009-2018. Public Health Nurs 2021;38:167-75. [PMID: 32935390 DOI: 10.1111/phn.12808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
145 Aravindakshan A, Boehnke J, Gholami E, Nayak A. The Impact of Mask-Wearing in Mitigating the Spread of COVID-19 During the Early Phases of the Pandemic.. [DOI: 10.1101/2020.09.11.20192971] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Hall EW, Bradley H. Gaps in Descriptive Epidemiology and Hepatitis C Virus Modeling Research. JAMA Netw Open 2020;3:e2016120. [PMID: 32880647 DOI: 10.1001/jamanetworkopen.2020.16120] [Reference Citation Analysis]
147 Trooskin S, Jhaveri R. Conversations With the Editors: Hepatitis C Virus-Where are We Now and Where Do We Go From Here? Clin Ther 2020;42:1425-32. [PMID: 32778344 DOI: 10.1016/j.clinthera.2020.07.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
148 Vadaparampil ST, Fuzzell LN, Rathwell J, Reich RR, Shenkman E, Nelson DR, Kobetz E, Jones PD, Roetzheim R, Giuliano AR. HCV testing: Order and completion rates among baby boomers obtaining care from seven health systems in Florida, 2015-2017. Prev Med 2021;153:106222. [PMID: 32721414 DOI: 10.1016/j.ypmed.2020.106222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
149 Pawlotsky J, Ramers CB, Dillon JF, Feld JJ, Lazarus JV. Simplification of Care for Chronic Hepatitis C Virus Infection. Semin Liver Dis 2020;40:392-402. [DOI: 10.1055/s-0040-1713657] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
150 Chappell CA, Scarsi KK, Kirby BJ, Suri V, Gaggar A, Bogen DL, Macio IS, Meyn LA, Bunge KE, Krans EE, Hillier SL. Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study. Lancet Microbe 2020;1:e200-8. [PMID: 32939459 DOI: 10.1016/S2666-5247(20)30062-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 16.5] [Reference Citation Analysis]
151 Jhaveri R. Screening for Hepatitis C Virus: How Universal Is Universal? Clin Ther 2020;42:1434-41. [PMID: 32712026 DOI: 10.1016/j.clinthera.2020.06.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
152 Coppock D, Chou E, Gracely E, Gross R, Heun-Lee D. Hepatitis C antibody screening and determinants of initial and duplicate screening in the baby boomer patients of six urban primary care clinics. PLoS One 2020;15:e0235778. [PMID: 32645083 DOI: 10.1371/journal.pone.0235778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
153 King H, Bull-Otterson L, Hoover KW, Huang HYA, Zhu W, Thompson W. Factors Associated With Testing for Hepatitis C Infections Among a Commercially Insured Population of Persons With HIV, United States 2008-2016. Open Forum Infect Dis 2020;7:ofaa222. [PMID: 32617381 DOI: 10.1093/ofid/ofaa222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
154 Havens PL, Anderson JR. Updated CDC Recommendations for Universal Hepatitis C Virus Screening Among Adults and Pregnant Women: Implications for Clinical Practice. JAMA 2020;323:2258-9. [PMID: 32271870 DOI: 10.1001/jama.2020.3693] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
155 Galbraith JW, Anderson ES, Hsieh YH, Franco RA, Donnelly JP, Rodgers JB, Schechter-Perkins EM, Thompson WW, Nelson NP, Rothman RE, White DAE. High Prevalence of Hepatitis C Infection Among Adult Patients at Four Urban Emergency Departments - Birmingham, Oakland, Baltimore, and Boston, 2015-2017. MMWR Morb Mortal Wkly Rep 2020;69:569-74. [PMID: 32407307 DOI: 10.15585/mmwr.mm6919a1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
156 Ryerson AB, Schillie S, Barker LK, Kupronis BA, Wester C. Vital Signs: Newly Reported Acute and Chronic Hepatitis C Cases - United States, 2009-2018. MMWR Morb Mortal Wkly Rep 2020;69:399-404. [PMID: 32271725 DOI: 10.15585/mmwr.mm6914a2] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 33.5] [Reference Citation Analysis]
157 Ćupić M. Hepatitis C: Three decades of the path from discovery to the Nobel prize. Srpski medicinski časopis Lekarske komore 2020;1:115-121. [DOI: 10.5937/smclk2002115c] [Reference Citation Analysis]